<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04500769</url>
  </required_header>
  <id_info>
    <org_study_id>43910</org_study_id>
    <secondary_id>3R01DK119619-02S1</secondary_id>
    <nct_id>NCT04500769</nct_id>
  </id_info>
  <brief_title>Training Induced Muscle Exosome Release</brief_title>
  <acronym>TIMER</acronym>
  <official_title>Exercise-induced Skeletal Muscle Exosomes Promote Adipocyte Lipolysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John McCarthy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to quantify miR-1 release from muscle in&#xD;
      extra-cellular vesicles following an acute resistance exercise bout and potential delivery to&#xD;
      subcutaneous adipose tissue in young healthy and obese adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Numerous studies in humans and animals have shown that aerobic exercise is beneficial to&#xD;
      adipose tissue function and whole-body metabolism. Both acute and chronic aerobic exercise&#xD;
      enhance adipocyte catecholamine sensitivity in humans and animals. Although relatively few&#xD;
      studies have investigated whether adipose adrenergic signaling is affected by resistance&#xD;
      exercise (RE), it is known that a single bout of RE can increase circulating NEFA and resting&#xD;
      energy expenditure and decrease respiratory quotient for up to 24 hours, indicative of&#xD;
      increased adipocyte lipolysis and muscle fatty acid oxidation. Furthermore, the lipolytic&#xD;
      response to RE is impaired in obese men. Using synergist ablation, a model of RE in mice, the&#xD;
      investigators show that adipose transcriptional responses are exosome-dependent, and that&#xD;
      serum exosomes enhance adipocyte catecholamine sensitivity and lipolysis for at least 24&#xD;
      hours. To the investigator's knowledge, this is the first demonstration of a potential&#xD;
      mechanism whereby RE imparts metabolic adaptations in adipose. Since adipose metabolic&#xD;
      function is crucial for determining whole-body metabolic outcomes, the ability of RE-induced&#xD;
      exosomes to improve adipose metabolism has significant clinical implications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>miR-1 abundance</measure>
    <time_frame>90 minutes</time_frame>
    <description>Exosomal, muscle, and adipose miR-1 abundance will be quantified at baseline and following an acute bout of resistance exercise by qPCR. Primary miR-1A/B abundance in muscle and adipose will also be quantified by qPCR. Mir-1 and primary miR-1A/B abundance will be normalized to U6 RNA or Rpl38 abundance,respectively, with normalized expression presented in arbitrary units.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Metabolism</condition>
  <arm_group>
    <arm_group_label>Acute Resistance Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will perform four exercises: squat, knee extension, leg press, and lat pulldown at 80% of 1-RM determined during a previous visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Acute Resistance Exercise</intervention_name>
    <description>Participants will perform three sets of eight repetitions, with a 90-120 second rest between sets, with a fourth set performed to failure. All resistance exercise will be performed on pneumatic resistance devices (Keiser Sports Health Equipment, Fresno, CA).</description>
    <arm_group_label>Acute Resistance Exercise</arm_group_label>
    <other_name>Strength Training</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-30 years of age.&#xD;
&#xD;
          -  Either BMI &lt;25 or &gt;30.&#xD;
&#xD;
          -  Relatively sedentary, reporting no participation in regular (&gt;1 day per week) exercise&#xD;
             for at least the past 3 months.&#xD;
&#xD;
          -  Non-smoker.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI between 25 and 30.&#xD;
&#xD;
          -  Evidence or signs and symptoms for cardiovascular disease (previous heart attack,&#xD;
             arrhythmias, angina, shortness of breath, extreme fatigue, unusual pain in neck, jaw,&#xD;
             throat, upper abdomen, or back, swelling in feet, legs, or ankles).&#xD;
&#xD;
          -  Evidence or signs and symptoms of metabolic syndrome or disorder (diagnosis of&#xD;
             diabetes or insulin resistance, elevated BP, high fasting blood sugar, abnormal&#xD;
             cholesterol or triglyceride levels).&#xD;
&#xD;
          -  Chronic aspirin or NSAID use (unless it can be safely stopped prior to the biopsies),&#xD;
             and any other use of an anticoagulant (e.g., Coumadin) or history of bleeding&#xD;
             including history of hypo- or hyper-coagulation disorders.&#xD;
&#xD;
          -  Neurological, musculoskeletal, or other disorder that would preclude safe&#xD;
             participation in the weight lifting tasks and all performance tests.&#xD;
&#xD;
          -  Any other medical condition that would interfere with testing or increase one's risk&#xD;
             of complications during exercise, as judged by the study physician.&#xD;
&#xD;
          -  Any other condition or events considered exclusionary by the PI and/or physician, such&#xD;
             as non-compliance.&#xD;
&#xD;
          -  Lidocaine allergy (1% lidocaine is the local anesthetic used during the muscle biopsy&#xD;
             procedure).&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John McCarthy, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Douglas Long, M.S.</last_name>
    <phone>859-323-5438</phone>
    <email>delong2@uky.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John McCarthy, Ph.D.</last_name>
    <phone>859-323-4730</phone>
    <email>jjmcca2@email.uky.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Long, M.S.</last_name>
      <phone>859-323-5438</phone>
      <email>delong2@uky.edu</email>
    </contact>
    <contact_backup>
      <last_name>John McCarthy, Ph.D.</last_name>
      <phone>859-323-4730</phone>
      <email>jjmcca2@email.uky.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Charlotte Peterson, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip Kern, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 29, 2020</study_first_submitted>
  <study_first_submitted_qc>August 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2020</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>John McCarthy</investigator_full_name>
    <investigator_title>Associate Professor, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Metabolism</keyword>
  <keyword>Muscle</keyword>
  <keyword>Extracellular Vesicles</keyword>
  <keyword>Exosomes</keyword>
  <keyword>Resistance Exercise</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

